American Express Co. buy BiotechBee
Start price
17.09.23
/
70%
€153.05
Target price
31.01.26
€200.00
Performance (%)
3.92%
End price
02.12.23
€159.05
Summary
This prediction ended on 02.12.23 with a price of €159.05. With a performance of 3.92%, the BUY prediction by BiotechBee for American Express Co. closed with a slight gain. Dividends of €0.57 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| American Express Co. | -4.314% | -4.314% | 11.153% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
According to BiotechBee what are the pros and cons of American Express Co. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread American Express Co. diskutieren
Buy mit Kursziel 200,0